These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7794347)

  • 1. Effects of oral pentoxifylline on TNF-alpha levels, transplant-related toxicities and engraftment after bone marrow transplantation.
    Lopez-Jimenez J; Cancelas JA; Valiño JM; Garcia-Laraña J; Garcia-Avello A; Arranz MI; Perez-Oteyza J; Ramos P; Odriozola J
    Bone Marrow Transplant; 1994 Dec; 14(6):1011-2. PubMed ID: 7794347
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
    Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients.
    Stockschläder M; Kalhs P; Peters S; Zeller W; Krüger W; Kabisch H; Lechner K; Zander A
    Bone Marrow Transplant; 1993 Oct; 12(4):357-62. PubMed ID: 8275035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pentoxifylline is not useful in the prevention of toxicity associated with bone marrow transplantation].
    López J; Cancelas JA; Valiño JM; García-Laraña J; Sastre JL; Pérez-Oteyza J; Cerveró C; García-Avello A; Cabezudo E; Arranz MI
    Med Clin (Barc); 1994 Apr; 102(13):485-8. PubMed ID: 8208006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation study.
    Beelen DW; Sayer HG; Franke M; Scheulen ME; Quabeck K; Mohnke M; Oidtmann M; Schaefer UW
    Bone Marrow Transplant; 1993 Oct; 12(4):363-70. PubMed ID: 8275036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of oral pentoxifylline on the cytokine release syndrome during inductive OKT3.
    DeVault GA; Kohan DE; Nelson EW; Holman JM
    Transplantation; 1994 Feb; 57(4):532-40. PubMed ID: 8116037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral pentoxyfylline on the OKT3-induced cytokine-release syndrome among renal allograft recipients.
    Vasquez EM; Pollak R
    Clin Transplant; 1996 Jun; 10(3):294-7. PubMed ID: 8826669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus.
    Murakami Y; Saito K; Hara A; Zhu Y; Sudo K; Niwa M; Fujii H; Wada H; Ishiguro H; Mori H; Seishima M
    J Neurochem; 2005 Jun; 93(6):1616-22. PubMed ID: 15935078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open study of the anti-TNF alpha agent pentoxifylline in the treatment of rheumatoid arthritis.
    Dubost JJ; Soubrier M; Ristori JM; Beaujon G; Oualid T; Bussière JL; Sauvezie B
    Rev Rhum Engl Ed; 1997 Dec; 64(12):789-93. PubMed ID: 9476267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    List AF; Maziarz R; Stiff P; Jansen J; Liesveld J; Andrews F; Schuster M; Wolff S; Litzow M; Karanes C; Dahlberg S; Kirkhart B; Bianco JA; Singer JW
    Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pentoxifylline on regimen related toxicity in patients undergoing allogeneic or autologous bone marrow transplantation.
    van der Jagt RH; Pari G; McDiarmid SA; Boisvert DM; Huebsch LB
    Bone Marrow Transplant; 1994 Feb; 13(2):203-7. PubMed ID: 8205090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pentoxifylline as adjuvant therapy of multiple organ failure].
    Schröder J; Staubach KH; Stüber F; Zabel P
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):461-5. PubMed ID: 14518297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial.
    Attal M; Huguet F; Rubie H; Charlet JP; Schlaifer D; Huynh A; Laurent G; Pris J
    Blood; 1993 Aug; 82(3):732-6. PubMed ID: 8338943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative oral pentoxifylline for management of cytokine reactions in cardiac surgery.
    Iskesen I; Kurdal AT; Kahraman N; Cerrahoglu M; Sirin BH
    Heart Surg Forum; 2009 Apr; 12(2):E100-4. PubMed ID: 19383582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
    Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
    Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between circulating cytokine levels and thyroid function following bone marrow transplantation.
    Lee WY; Kang MI; Oh KW; Oh ES; Baek KH; Lee KW; Kim SW; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2004 Jan; 33(1):93-8. PubMed ID: 14704661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study.
    Bianco JA; Almgren J; Kern DL; Ballard B; Roark K; Andrews F; Nemunaitis J; Shields T; Singer JW
    Transplantation; 1991 Apr; 51(4):925-7. PubMed ID: 2014558
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma levels of TNF and IL-6 following induction of acute pancreatitis and pentoxifylline treatment in rats.
    Márton J; Farkas G; Nagy Z; Takács T; Varga J; Szász Z; Balogh A; Lonovics J
    Acta Chir Hung; 1997; 36(1-4):223-5. PubMed ID: 9408354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
    Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
    Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.